LymphoDrain SIGNED
First subcutaneous implant to treat lymphedema. Definitive solution for chronic lymphedema
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0LymphoDrain project word cloud
Explore the words cloud of the LymphoDrain project. It provides you a very rough idea of what is the project "LymphoDrain" about.
Project "LymphoDrain" data sheet
The following table provides information about the project.
| Coordinator |
LYMPHATICA MEDTECH SA
Organization address contact info |
| Coordinator Country | Switzerland [CH] |
| Project website | http://www.lymphatica.ch |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-12-01 to 2018-03-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | LYMPHATICA MEDTECH SA | CH (LAUSANNE) | coordinator | 50˙000.00 |
Map
Project objective
Lymphatica Medtech S.A. is a spin-off company created in 2017, from the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Lausanne University Hospital (CHUV). It has designed and patented “LymphoDrain” a novel implantable system to replace the lymphatic vessel draining function to treat lymphatic disorders, in particular chronic lymphedema. It uses an underlying technology based on a magnetically controlled micro-pump coupled with draining catheters. LymphoDrain was developed by Dr. Marco Pisano and Dr. Valentina Triacca, in the Laboratory of Lymphatic and Cancer Bioengineering led by Prof. Melody Swartz. Since the initial invention, a multidisciplinary and highly qualified team has participated in the project bringing clinical perspective and attracting financial support from several organizations (CTI grant, FIT grant, AIT innovation grant). The recognition has been received at both national (Winner of Venture Kick stage I and II, Top3 at Venture Business Plan Competition 2016) and international level (finalist at Imagine IF Accelerator 2016, Top 2 at TERMIS-EU Business Plan Competition 2016). At the moment, Lymphatica is a finalist in the MassChallenge Switzerland Awards 2017 on a trajectory of unstoppable growth and recognition. LymphoDrain technology was consciously designed as an implantable system to cover the needs of a segment of the population, estimated at more than 15 million people in Europe and US who suffer of chronic lymphedema and presently lack effective treatments. The functionality of LymphoDrain has been successfully tested in large animal models. This vision positions LymphoDrain in a unique situation to access both the European and the US health care market as a disruptive technology in the treatment of lymphedema.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYMPHODRAIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LYMPHODRAIN" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)
Meshporto_smeIns1_2 (2018)
PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.
Read MoreAssist (2015)
Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone
Read More